References

  1. Glick M, Williams D. Vision 2020 Think Tank - A new definition for oral health. FDI World Dental Federation. Accessed November 4, 2019.
  2. Sreebny L, Vissink A. Dry Mouth: the malevolent symptom: a clinical guide. Ames, Iowa. Wiley-Blackwell. May 2010.
  3. Anil S, Velappally S, Hashem M, et al. Xerostomia in geriatric patients: a burgeoning global concern. J Investig Clin Dent. 2016 Feb;7(1):5-12. doi: 10.1111/jicd.12120. Epub 2014 Sep 1.
  4. Ouanounou A. Xerostomia in the geriatric patient: causes, oral manifestations, and treatment. Compend Contin Educ Dent. 2016 May;37(5):306-311;quiz312. Review.
  5. Olate S, Muñoz D, Neumann S, et al. A descriptive study of the oral status in subjects with Sjögren's syndrome. Int J Clin Exp Med. 2014 Apr 15;7(4):1140-4. eCollection 2014.
  6. Abdelghany A, Nolan A, Freeman R. Treating patients with dry mouth: general dental practitioners' knowledge, attitudes and clinical management. Br Dent J. 2011 Nov 25;211(10):E21. doi: 10.1038/sj.bdj.2011.966.
  7. Han P, Suarez-Durall P, Mulligan R. Dry mouth: a critical topic for older adult patients. J Prosthodont Res. 2015 Jan;59(1):6-19. doi: 10.1016/j.jpor.2014.11.001. Epub 2014 Dec 9.
  8. Plemons JM, Al-Hashimi I, Marek CL; Managing xerostomia and salivary gland hypofunction: executive summary of a report from the American Dental Association Council on Scientific Affairs. J Am Dent Assoc. 2014 Aug;145(8):867-73. doi: 10.14219/jada.2014.44.
  9. Hopcraft MS, Tan C. Xerostomia: an update for clinicians. Aust Dent J. 2010 Sep;55(3):238-44; quiz 353. doi: 10.1111/j.1834-7819.2010.01229.x.
  10. Ngo DYJ, Thomson WM, Nolan A, Ferguson S. The lived experience of Sjögren's Syndrome. BMC Oral Health. 2016 Feb 1;16:7. doi: 10.1186/s12903-016-0165-4.
  11. Mandel ID. The functions of saliva. J Dent Res. 1987 Feb;66 Spec No:623-7.
  12. Pedersen AML, Sørensen CE, Proctor GB, Carpenter GH, Ekström J. Salivary secretion in health and disease. J Oral Rehabil. 2018 Jun 7. doi: 10.1111/joor.12664. [Epub ahead of print]
  13. Islas-Granillo H, Borges-Yañez SA, Navarrete-Hernández JJ, et al. Indicators of oral health in older adults with and without the presence of multimorbidity: a cross-sectional study. Clin Interv Aging. 2019 Jan 30;14:219-224. doi: 10.2147/CIA.S170470. eCollection 2019.
  14. Benn AM, Broadbent JM, Thomson WM. Occurrence and impact of xerostomia among dentate adult New Zealanders: findings from a national survey. Aust Dent J. 2015 Sep;60(3):362-7. doi: 10.1111/adj.12238. Epub 2015 Jul 24.
  15. Segal B, Bowman SJ, Fox PC, et al. Primary Sjögren's Syndrome: health experiences and predictors of health quality among patients in the United States. Health Qual Life Outcomes. 2009 May 27;7:46. doi: 10.1186/1477-7525-7-46.
  16. Tanasiewicz M, Hildebrandt T, Obersztyn I. Xerostomia of various etiologies: a review of the literature. Adv Clin Exp Med. 2016 Jan-Feb;25(1):199-206. doi: 17219/acem/29375.
  17. Hahnel S, Schwarz S, Zeman F, et al. Prevalence of xerostomia and hyposalivation and their association with quality of life in elderly patients in dependence on dental status and prosthetic rehabilitation: a pilot study. J Dent.2014 Jun;42(6):664-70. doi: 10.1016/j.jdent.2014.03.003. Epub 2014 Mar 14.
  18. Ramsay SE, Whincup PH, Watt RG, et al. Burden of poor oral health in older age: findings from a population-based study of older British men. BMJ Open. 2015 Dec 29;5(12):e009476. doi: 10.1136/bmjopen-2015-009476.
  19. Baer AN, Walitt B. Sjögren Syndrome and other causes of sicca in older adults. Clin Geriatr Med. 2017 Feb;33(1):87-103. doi: 10.1016/j.cger.2016.08.007. Review.
  20. Thomson WM, Lawrence HP, Broadbent JM, et al. The impact of xerostomia on oral-health-related quality of life among younger adults. Health Qual Life Outcomes. 2006 Nov 8;4:86. doi: 10.1186/1477-7525-4-86.
  21. Flink H. Studies on the prevalence of reduced salivary flow rate in relation to general health and dental caries, and effect of iron supplementation. Swed Dent J Suppl. 2007;(192):3-50, 2 p preceding table of contents.
  22. Lynge Pedersen AM, Nauntofte B, Smidt D, et al. Oral mucosal lesions in older people: relation to salivary secretion, systemic diseases and medications. Oral Dis. 2015 Sep;21(6):721-9. doi: 10.1111/odi.12337. Epub 2015 Apr 6.
  23. Al-Hashimi I. Xerostomia secondary to Sjögren's syndrome in the elderly: recognition and management. Drugs Aging. 2005;22(11):887-99. doi: 10.2165/00002512-200522110-00001.
  24. Gil-Montoya JA, de Mello AL, Barrios R, et al. Oral health in the elderly patient and its impact on general well-being: a nonsystematic review. Clin Interv Aging. 2015 Feb 11;10:461-7. doi: 10.2147/CIA.S54630. eCollection 2015.
  25. Niklander S, Veas L, Barrera C, et al. Risk factors, hyposalivation and impact of xerostomia on oral health-related quality of life. Braz Oral Res. 2017 Jan 16;31:e14. doi:10.1590/1807-3107BOR-2017.vol31.0014.
  26. Porter J, Ntouva A, Read A, et al. The impact of oral health on the quality of life of nursing home residents. Health Qual Life Outcomes. 2015 Jul 15;13:102. doi: 10.1186/s12955-015-0300-y.
  27. Wiener RC, Wu B, Crout R, et al. Hyposalivation and xerostomia in dentate older adults. J Am Dent Assoc. 2010 Mar;141(3):279-84.doi: 10.14219/jada.archive.2010.0161.
  28. Singh PB, Young A, Homayouni A, et al. Distorted taste and impaired oral health in patients with sicca complaints. Nutrients. 2019 Jan 24;11(2). pii: E264. doi:10.3390/nu11020264.
  29. Rusthen S, Young A, Herlofson BB, et al. Oral disorders, saliva secretion, and oral health-related quality of life in patients with primary Sjögren's syndrome. Eur J Oral Sci. 2017 Aug;125(4):265-271. doi: 10.1111/eos.12358. Epub 2017 Jun 23.
  30. Bekes K, Hirsch C. What is known about the influence of dentine hypersensitivity on oral health-related quality of life? Clin Oral Investig. 2013 Mar;17 Suppl 1:S45-51. doi: 10.1007/s00784-012-0888-9. Epub 2012 Dec 6.
  31. Hara AT, Zero DT. The potential of saliva in protecting against dental erosion. Monogr Oral Sci. 2014;25:197-205.
  32. Ekstrom J, Khosravani N, Castagnola M, et al. Saliva and its control of secretions. Dysphagia,Medical Radiology. Diagnostic Imaging. Ed. Ekberg O. Springer-Verlag Berlin Heidelberg 2012.
  33. de Almeida Pdel V, Grégio AM, Machado MA, et al. Saliva composition and functions: a comprehensive review. J Contemp Dent Pract. 2008 Mar 1;9(3):72-80.
  34. Osailan SM, Pramanik R, Shirlaw P, et al. Clinical assessment of oral dryness: development of a scoring system related to salivary flow and mucosal wetness. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012 Nov;114(5):597-603. doi: 10.1016/j.oooo.2012.05.009. Epub 2012 Sep 7.
  35. Jager DHJ, Bots CP, Forouzanfar T, et al. Clinical oral dryness score: evaluation of a new screening method for oral dryness. Odontology. 2018 Oct;106(4):439-444. doi: 10.1007/s10266-018-0339-4. Epub 2018 Jan 22.
  36. Longman LP, McCracken CF, Higham SM, et al The clinical assessment of oral dryness is a significant predictor of salivary gland hypofunction. Oral Dis. 2000 Nov;6(6):366-70.
  37. Lussi A, Schlueter N, Rakhmatullina E, et al. Dental erosion--an overview with emphasis on chemical and histopathological aspects. Caries Res. 2011;45 Suppl 1:2-12. doi: 10.1159/000325915. Epub 2011 May 31.
  38. Wolff M, Kleinberg I. Oral mucosal wetness in hypo- and normosalivators. Arch Oral Biol. 1998 Jun;43(6):455-62. doi: 10.1016/s0003-9969(98)00022-3.
  39. Barbour ME, Lussi A. Erosion in relation to nutrition and the environment. Monogr Oral Sci. 2014;25:143-54. doi: 10.1159/000359941. Epub 2014 Jun 26.
  40. Almståhl A, Wikström M. Electrolytes in stimulated whole saliva in individuals with hyposalivation of different origins. Arch Oral Biol. 2003 May;48(5):337-44. doi: 10.1016/s0003-9969(02)00200-5.
  41. Burne RA, Zeng L, Ahn SJ, et al. Progress dissecting the oral microbiome in caries and health. Adv Dent Res. 2012 Sep;24(2):77-80. doi: 10.1177/0022034512449462.
  42. Marsh PD. Are dental diseases examples of ecological catastrophes? Microbiology. Microbiology. 2003 Feb;149(Pt 2):279-94. doi: 10.1099/mic.0.26082-0.
  43. Eliasson L, Carlén A, Almståhl A, et al. Dental plaque pH and micro-organisms during hyposalivation. J Dent Res. 2006 Apr;85(4):334-8. doi: 10.1177/154405910608500410.
  44. Almståhl A, Wikström M. Oral microflora in subjects with reduced salivary secretion. J Dent Res. 1999 Aug;78(8):1410-6. doi: 10.1177/00220345990780080601.
  45. Almståhl A, Wikström M. Microflora in oral ecosystems in subjects with hyposalivation due to medicines or of unknown origin. Oral Health Prev Dent. 2005;3(2):67-76.
  46. Aas JA, Griffen AL, Dardis SR,et al. Bacteria of dental caries in primary and permanent teeth in children and young adults. J Clin Microbiol. 2008 Apr;46(4):1407-17. doi: 10.1128/JCM.01410-07. Epub 2008 Jan 23.
  47. Takahashi N, Nyvad B. The role of bacteria in the caries process: ecological perspectives. J Dent Res. 2011 Mar;90(3):294-303. doi: 10.1177/0022034510379602. Epub 2010 Oct 5.
  48. Falsetta ML, Klein MI, Colonne PM, et al. Symbiotic relationship between Streptococcus mutans and Candida albicans synergizes virulence of plaque biofilms in vivo. Infect Immun. 2014 May;82(5):1968-81. doi: 10.1128/IAI.00087-14. Epub 2014 Feb 24.
  49. Li Y, Ge Y, Saxena D, et al. Genetic profiling of the oral microbiota associated with severe early-childhood caries. J Clin Microbiol. 2007Jan;45(1):81-7. doi: 10.1128/JCM.01622-06.
  50. Preza D, Olsen I, Aas JA, et al. Bacterial profiles of root caries in elderly patients. J Clin Microbiol. 2008 Jun;46(6):2015-21. doi: 10.1128/JCM.02411-07. Epub 2008 Apr 2.
  51. Jenkinson HF, Douglas LJ. Chapter 18 Interactions between Candida Species and Bacteria in Mixed Infections. Polymicrobial Diseases. Washington (DC): ASM Press; 2002.
  52. Absi EG, Addy M, Adams D. Dentine hypersensitivity. A study of the patency of dentinal tubules in sensitive and non-sensitive cervical dentine. ClinPeriodontol. 1987 May;14(5):280-4. doi: 10.1111/j.1600-051x.1987.tb01533.x.
  53. Zero DT, Lussi A. Erosion--chemical and biological factors of importance to the dental practitioner. Int Dent J. 2005;55(4 Suppl 1):285-90.
  54. Morishita S, Watanabe Y, Ohara Y, et al. Factors associated with older adults' need for oral hygiene management by dental professionals. Geriatr Gerontol Int. 2016 Aug;16(8):956-62. doi: 10.1111/ggi.12585. Epub 2015 Sep 3.
  55. Noboru Kuroiwa D, Ruiz Da Cunha Melo MA, Balducci I, et al. Evaluation of salivary flow and drug interactions in patients with a diagnosis of diabetes mellitus. Minerva Stomatol. 2014 Nov-Dec;63(11-12):421-6.
  56. Matsuoka H, Chiba I, Sakano Y, et al. The effect of cognitive appraisal for stressors on the oral health-related QOL of dry mouth patients. Biopsychosoc Med. 2014 Oct 22;8:24. doi: 10.1186/1751-0759-8-24. eCollection 2014.
  57. Abrão AL, Santana CM, Bezerra AC, et al. What rheumatologists should know about orofacial manifestations of autoimmune rheumatic diseases. Rev Bras Reumatol Engl Ed. 2016 Sep - Oct;56(5):441-450. doi: 10.1016/j.rbre.2016.02.006. Epub 2016 Mar 16. Review.
  58. Hadj Said M, Foletti JM, Graillon N, et al. Orofacial manifestations of scleroderma. A literature review. Rev Stomatol Chir Maxillofac Chir Orale. 2016 Nov;117(5):322-326. doi: 10.1016/j.revsto.2016.06.003. Epub 2016 Jul 27.
  59. Oyetola EO, Owotade FJ, Agbelusi GA, et al. Oral findings in chronic kidney disease: implications for management in developing countries. BMC Oral Health. 2015 Feb 20;15:24. doi: 10.1186/s12903-015-0004-z.
  60. Grønkjær LL, Vilstrup H. Oral health in patients with liver cirrhosis. Eur J Gastroenterol Hepatol. 2015 Jul;27(7):834-9. doi: 10.1097/MEG.0000000000000356.
  61. Agha-Hosseini F, Shirzad N, Moosavi MS. Evaluation of Xerostomia and salivary flow rate in Hashimoto's Thyroiditis. Med Oral Patol Oral Cir Bucal. 2016 Jan 1;21(1): e1-5. doi: 10.4317/medoral.20559.
  62. Nordén J, Grönberg AM, Bosaeus I, et al. Nutrition impact symptoms and body composition in patients with COPD. Eur J Clin Nutr. 2015 Feb;69(2):256-61. doi: 10.1038/ejcn.2014.76. Epub 2014 May 7.
  63. Corrêa MC, Lerco MM, Cunha Mde L, et al. Salivary parameters and teeth erosions in patients with gastroesophageal reflux disease. Arq Gastroenterol. 2012 Jul-Sep;49(3):214-8.
  64. Usmani ZA, Hlavac M, Rischmueller M,et al. Sleep disordered breathing in patients with primary Sjögren's syndrome: a group controlled study. Sleep Med. 2012 Sep;13(8):1066-70. doi: 10.1016/j.sleep.2012.06.010. Epub 2012 Jul 25.
  65. Nakajima N. Characteristics of oral problems and effects of oral care in terminally ill patients with cancer. Am J Hosp Palliat Care. 2017Jun;34(5):430-434. doi: 10.1177/1049909116633063. Epub 2016 Feb 22.
  66. Rohr Y, Adams J, Young L. Oral discomfort in palliative care: results of an exploratory study of the experiences of terminally ill patients. Int J PalliatNurs. 2010 Sep;16(9):439-44. doi: 10.12968/ijpn.2010.16.9.78638.
  67. Fischer DJ, Epstein JB, Yao Y, et al. Oral health conditions affect functional and social activities of terminally ill cancer patients. Support Care Cancer. 2014 Mar;22(3):803-10. doi: 10.1007/s00520-013-2037-7.
  68. Faris M. Clinical estimation of survival and impact of other prognostic factors on terminally ill cancer patients in Oman. Support Care Cancer. 2003 Jan;11(1):30-4. Epub 2002 Oct 29. doi: 10.1007/s00520-002-0401-0.
  69. Bostock C, McDonald C. Antimuscarinics in older people: dry mouth and beyond. dent update. 2016 Mar;43(2):186-8, 191. doi: 10.12968/denu.2016.43.2.186.
  70. Balakumar P, Kavitha M, Nanditha S. Cardiovascular drugs-induced oral toxicities: a murky area to be revisited and illuminated. Pharmacol Res. 2015 Dec;102:81-9. doi: 10.1016/j.phrs.2015.09.007. Epub 2015 Sep 25.
  71. Delli K, Spijkervet FK, Kroese FG, et al. Xerostomia. Monogr Oral Sci. 2014;24:109-25. doi: 10.1159/000358792. Epub 2014 May 23.
  72. Fratto G, Manzon L. Use of psychotropic drugs and associated dental diseases. Int J Psychiatry Med. 2014;48(3):185-97. doi: 10.2190/PM.48.3.d.
  73. Heaton LJ, Swigart K, McNelis G, et al. Oral health inpatients taking psychotropic medications: Results from a pharmacy-based pilot study. J Am Pharm Assoc (2003). 2016 Jul-Aug;56(4):412-417.e1. doi: 10.1016/j.japh.2016.03.009. Epub 2016 Jun 3.
  74. Habbab KM, Moles DR, Porter SR. Potential oral manifestations of cardiovascular drugs. Oral Dis. 2010 Nov;16(8):769-73. doi: 10.1111/j.1601-0825.2010.01686.x.
  75. Prasanthi B, Kannan N, Patil R. Effect of Diuretics on Salivary Flow, Composition and Oral Health Status: A Clinico-biochemical Study. Ann Med Health Sci Res. 2014 Jul;4(4):549-53. doi: 10.4103/2141-9248.139311.
  76. Fukushima Y, Sano Y, Isozaki Y, et al. A pilot clinical evaluation of oral mucosal dryness in dehydrated patients using a moisture-checking device. Clin Exp Dent Res. 2019 Feb 7;5(2):116-120. doi: 10.1002/cre2.145. eCollection 2019 Apr.
  77. Mulic A, Tveit AB, Songe D, et al. Dental erosive wear and salivary flow rate in physically active young adults. BMC Oral Health. 2012 Mar 23;12:8. doi: 10.1186/1472-6831-12-8.
  78. Pontefract H, Hughes J, Kemp K, et al. The erosive effects of some mouth rinses on enamel. A study in situ. J Clin Periodontol. 2001 Apr;28(4):319-24. doi: 10.1034/j.1600-051x.2001.028004319.x.

Additional Resources

  • No Additional Resources Available